USA News Group - News Commentary - Depression remains one of the most stubborn problems in modern medicine, and the numbers ...
HLP003 previously granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration ("FDA”) HLP003 Phase 2 data demonstrated durable efficacy, with a mean ~23-po ...
The stock is being punished for Entresto’s 50% sales drop, but the quarter still beat on core operating profit thanks to ...
Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance ...
The drug from Merck was OK’d for patients with artery-clogging cholesterol that persists even after taking statins.
The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...
The New Mexico Environment Department (NMED) has updated its website to include information on per- and polyfluoroalkyl substances (PFAS) in ...
Officials under <a href=" Donald Trump want to make it easier for men to get a <a href=" for testosterone, the latest shift ...
HHS Secretary RFK Jr. is announcing updated FDA standards for pasteurized orange juice. Here is what the 10% Brix shift means ...
Comments from FDA and USDA’s 2025 RFI for a UPF definition suggest the main debate is no longer whether UPFs exist, but ...
The Food and Drug Administration has approved a powerful new kind of cholesterol-lowering drug.
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results